메뉴 건너뛰기





Volumn 4, Issue 6, 2012, Pages 648-652

IBC's 23rd antibody engineering and 10th antibody therapeutics conferences, and the Annual Meeting of the Antibody Society: December 2-6, 2012, San Diego, CA

Author keywords

Antibody engineering; Antibody therapeutics; Antibody drug conjugates; Bispecific antibodies; Intellectual property law

Indexed keywords

BAVITUXIMAB; BEVACIZUMAB; BRENTUXIMAB VEDOTIN; CD47 ANTIGEN; CETUXIMAB; IMMUNOMODULATING AGENT; IPILIMUMAB; MONOCLONAL ANTIBODY; PANITUMUMAB; RECOMBINANT ANTIBODY; RECOMBINANT CYTOKINE; RITUXIMAB; TRASTUZUMAB; VEDOLIZUMAB;

EID: 84869764284     PISSN: 19420862     EISSN: 19420870     Source Type: Journal    
DOI: 10.4161/mabs.22221     Document Type: Conference Paper
Times cited : (1)

References (0)
  • Reference 정보가 존재하지 않습니다.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.